P3 Health extends $19M draw period on $40M promissory note tranche to June 30, 2026

P3 Health Partners Inc.

Amendment to existing $40M third tranche allows draws of remaining $19M through June 30, 2026.
Originally dated May 29, 2025; all other Note terms unchanged.
No new borrowing; simply extends draw availability on previously committed facility.
Counterparty is VBC Growth SPV 5, LLC (affiliate of Chicago Pacific Founders).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

P3 Health Partners Inc. amended Amendment to Unsecured Promissory Note with VBC Growth SPV 5, LLC valued at $19.0 million (effective 2026-02-11).

Action: amendment
Agreement: notes offering
Counterparty: VBC Growth SPV 5, LLC
Value: $19.0 million
Effective: 2026-02-11

Exact text from the filing

On February 11, 2026, P3 Health Group, LLC (the “Company”) entered into an Amendment to Unsecured Promissory Note (the “Amendment”) with VBC Growth SPV 5, LLC (the “Holder”) amending the terms of the Unsecured Promissory Note originally dated May 29, 2025 (the “Note). The Amendment modifies Section 1, clause (a)(iii) of the Note to extend the availability period for the third tranche of funding. Under the Amendment, the remaining $19.0 million of the third tranche is available for one or more draws through June 30, 2026.

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

P3 Health Partners Inc. filing history →

Source: SEC EDGAR

accession 0001832511-26-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.